Literature DB >> 12825872

The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years.

G Gondal1, T Grotmol, B Hofstad, M Bretthauer, T J Eide, G Hoff.   

Abstract

BACKGROUND: Randomized controlled trials of sufficient power testing the long-term effect of screening for colorectal neoplasia only exist for faecal occult blood testing (FOBT). There is indirect evidence that flexible sigmoidoscopy (FS) may have a greater yield. The aim of this study was to determine the diagnostic yield of screening with FS or a combination of FS and FOBT in an average-risk population in an urban and combined urban and rural population in Norway.
METHODS: 20,780 men and women (1:1), aged 50-64 years, were invited for once-only screening (FS only or a combination of FS and FOBT (1:1)) by randomization from the population registry. A positive FS was defined as a finding of any neoplasia or any polyp > or = 10 mm. A positive FS or FOBT qualified for colonoscopy.
RESULTS: Overall attendance was 65%. Forty-one (0.3%) cases of CRC were detected. Any adenoma was found in 2208 (17%) participants and 545 (4.2%) had high-risk adenomas. There was no difference in diagnostic yield between the FS and the FS and FOBT group regarding CRC or high-risk adenoma. Work-up load comprised 2821 colonoscopies in 2524 (20%) screenees and 10% of screenees were recommended later colonoscopy surveillance. There were no severe complications at FS, but six perforations after therapeutic colonoscopy (1:336).
CONCLUSIONS: The present study bodes well for future management of a national screening programme, provided that follow-up results reflect adequate proof of a net benefit. It is highly questionable whether the addition of once-only FOBT to FS will contribute to this effect.

Entities:  

Mesh:

Year:  2003        PMID: 12825872     DOI: 10.1080/00365520310003002

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  45 in total

1.  Evaluation of complications related to therapeutic colonoscopy using the bipolar snare.

Authors:  Tsutomu Saraya; Hiroaki Ikematsu; Kuang I Fu; Chihiro Tsunoda; Yusuke Yoda; Yasuhiro Oono; Takashi Kojima; Tomonori Yano; Takahiro Horimatsu; Yasushi Sano; Kazuhiro Kaneko
Journal:  Surg Endosc       Date:  2011-09-23       Impact factor: 4.584

Review 2.  The value of models in informing resource allocation in colorectal cancer screening: the case of The Netherlands.

Authors:  Frank van Hees; Ann G Zauber; Harriët van Veldhuizen; Marie-Louise A Heijnen; Corine Penning; Harry J de Koning; Marjolein van Ballegooijen; Iris Lansdorp-Vogelaar
Journal:  Gut       Date:  2015-06-10       Impact factor: 23.059

Review 3.  Health disparities in colorectal cancer among racial and ethnic minorities in the United States.

Authors:  Christian S Jackson; Matthew Oman; Aatish M Patel; Kenneth J Vega
Journal:  J Gastrointest Oncol       Date:  2016-04

4.  Diagnostic performance of fecal immunochemical test and sigmoidoscopy for advanced right-sided colorectal neoplasms.

Authors:  Inés Castro; Pamela Estevez; Joaquín Cubiella; Vicent Hernandez; Carmen González-Mao; Concepción Rivera; Felipe Iglesias; Lucía Cid; Santiago Soto; Luisa de-Castro; Pablo Vega; Jose Antonio Hermo; Ramiro Macenlle; Alfonso Martínez; Estela Cid; Inés Gil; Mikel Larzabal; Luis Bujanda; Antoni Castells
Journal:  Dig Dis Sci       Date:  2014-11-19       Impact factor: 3.199

5.  Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy.

Authors:  Adeyinka O Laiyemo; Chyke Doubeni; Paul F Pinsky; V Paul Doria-Rose; Andrew K Sanderson; Robert Bresalier; Joel Weissfeld; Robert E Schoen; Pamela M Marcus; Philip C Prorok; Christine D Berg
Journal:  Cancer Epidemiol       Date:  2011-11-22       Impact factor: 2.984

6.  Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.

Authors:  Øyvind Holme; Magnus Løberg; Mette Kalager; Michael Bretthauer; Miguel A Hernán; Eline Aas; Tor J Eide; Eva Skovlund; Jørn Schneede; Kjell Magne Tveit; Geir Hoff
Journal:  JAMA       Date:  2014-08-13       Impact factor: 56.272

7.  Collagen mRNA levels changes during colorectal cancer carcinogenesis.

Authors:  Hanne Skovbjerg; Dorit Anthonsen; Inger M B Lothe; Kjell M Tveit; Elin H Kure; Lotte K Vogel
Journal:  BMC Cancer       Date:  2009-05-07       Impact factor: 4.430

8.  Risk of colorectal cancer seven years after flexible sigmoidoscopy screening: randomised controlled trial.

Authors:  Geir Hoff; Tom Grotmol; Eva Skovlund; Michael Bretthauer
Journal:  BMJ       Date:  2009-05-29

9.  A colorectal cancer screening program in an underserved, ethnically diverse population in Chicago, IL.

Authors:  Andrew J Gawron; Barbara Jung; Angela J Fought; Babs H Waldman; Neehar D Parikh
Journal:  J Community Health       Date:  2013-08

10.  Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.

Authors:  Joanna Selzer-Plon; Jette Bornholdt; Stine Friis; Hanne C Bisgaard; Inger Mb Lothe; Kjell M Tveit; Elin H Kure; Ulla Vogel; Lotte K Vogel
Journal:  BMC Cancer       Date:  2009-06-25       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.